Menarini Receives FDA Orphan Drug Designation for SEL24/MEN1703, a first in class, dual PIM/FLT3 inhibitor for the Treatment of Acute Myeloid Leukemia

The Menarini Group announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation (ODD) to SEL24/MEN1703 for the treatment of Acute Myeloid Leukemia (AML). SEL24/MEN1703 is a first-in-class, orally available, dual PIM/FLT3 inhibitor, in-licensed by Menarini from Ryvu Therapeutics, and currently investigated in the DIAMOND-01 trial as a single agent for […]

thaipr.net

5 พ.ย. 64

thaipr.net

5 พ.ย. 64

Straive featured in ISG Provider Lens™ Contact Center — Customer Experience Services 2021 Global report

Straive (erstwhile SPi Global), a market-leader in technology driven EdTech, content, and data solutions, has been named a contender across global geographies by advisory firm Information Services Group (ISG) in its Provider Lens™ Contact Center — Customer Experience Services 2021 global report. Straive has been featured in multiple quadrants, including Digital Operations, AI & Analytics, Work from Home Services […]

thaipr.net

5 พ.ย. 64
1 2,560 2,561 2,562 2,563 2,564 3,226